Bayer has teamed up with consulting firm ZS to overhaul its demand‑forecasting processes through advanced artificial intelligence and machine learning techniques. The collaboration aims to replace traditional planner‑driven methods, which often rely on manual adjustments and fragmented data sources, with a unified AI model that predicts product demand more accurately across global markets. Early trials suggest improvements in forecast precision and inventory optimization.
By automating data integration and applying predictive analytics, Bayer expects to reduce excess stock, lower supply‑chain costs, and enhance responsiveness to market fluctuations. The initiative reflects a broader trend of legacy industries adopting AI to modernize operations, and it may set a benchmark for other pharmaceutical and consumer‑goods companies seeking digital transformation. Stakeholders are watching closely to gauge the impact on Bayer’s financial performance and operational efficiency.
This story was written by a language model from reporting by SCMR. Check the original before quoting it.